In other countries
The same active substances on other registers, the same brand first.
- Apo-EslicarbazepineCanada · 200 MG · Tablet · Apotex INCSame form
- Apo-EslicarbazepineCanada · 600 MG · Tablet · Apotex INCSame form
- Apo-EslicarbazepineCanada · 400 MG · Tablet · Apotex INCSame form
- ArupsanItaly · Compressa · Accord Healthcare, S.L.U.Same form
- Eslicarbazepina Acetato AurobindoItaly · Compressa · Aurobindo Pharma (Italia) S.R.L.Same form
- Eslicarbazepina DocItaly · Compressa · Doc Generici SRLSame form
- Eslibon 200 mg tablettenNetherlands · Tablet · G.L. Pharma GmbHSame form
- Eslibon 400 mg tablettenNetherlands · Tablet · G.L. Pharma GmbHSame form
- Eslibon 600 mg tablettenNetherlands · Tablet · G.L. Pharma GmbHSame form
- AptiomUnited States · 200MG, 400MG, 600MG … · tablet · Sumitomo Pharma AmSame form
- Eslicarbazepine AcetateUnited States · 200MG, 400MG, 600MG … · tablet · LupinSame form
- ZebinixEuropean Union · BIAL - Portela & Ca, S.A.Same substance
- ExaliefEuropean Union · BIAL - Portela Ca, S.A.Same substance
- ZebinixCroatiaSame substance
Packs
| Pack | Code | Status |
|---|---|---|
| ESCARPILO 800 MG COMPRIMIDOS EFG, 30 comprimidos | 729677 | |
| ESCARPILO 800 MG COMPRIMIDOS EFG, 60 comprimidos | 764685 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Eslicarbazepine
- Strength
- 800 mg
- Dosage form
- comprimido
- Route
- vía oral
- Register
- Spain (AEMPS)
- Status
- Marketed
- Status in the register
- Autorizado, comercializado
- Authorised
- 6 Nov 2020
- Registration
- 85543
- Marketing authorisation holder
- Neuraxpharm Spain S.L.
- Procedure
- National, MRP or DCP
- Supply
- Medicamento Sujeto A Prescripción Médica